← FDA ENFORCEMENT
D-0113-2024Class III

NCS Healthcare of Kentucky Inc

Recalling firm
NCS Healthcare of Kentucky Inc
Product type
Drug
Status
Terminated
Report date
2023-11-29
Distribution
Nationwide USA
Firm state
KY
Product quantity
1,344 cards
Initiated by
Voluntary: Firm initiated
Reason for recall

Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots

Product description

Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39), Rx only, Mfd By Pliva HRVATSKA for Teva USA, PKG by Vangard Glasgow, KY 42141.

Code / lot info

Lot#: a) 7718-3008, Exp 08/31/2024; b) 7718-3008, Exp 08/31/2024

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.